FGF23 and Marchiafava-Bignami disease: In murine CKD-MBD, the CKD-driven increase in ostoblastic and osteocytic FGF23 synthesis contributes to mineralization defects and accumulation of the mineralizing inhibitor pyrophosphate in bone [16].